An article authored by SSJR Member, Benjamin Lehberger, has been published in the June 2015 issue of European Pharmaceutical Manufacturer Magazine. The article discusses Inter Partes Review (IPR) challenges being brought by the Coalition for Affordable Drugs against pharmaceutical patents. The Coalition, backed by Hayman Capital Management LP, reportedly seeks to profit from the challenges by betting against the patent owners’ stocks. The article discusses tips on what a publicly traded company can do to reduce the risk of losing patent protection and their stock value to an IPR attack.

Click here to download a copy of the article